You are here: Industry Insights > COVID-19

News List

Singapore approves Gilead’s remdesivir to treat Covid-19 pharmaceutical-technology
June 15, 2020
Singapore’s Health Sciences Authority (HSA) has awarded conditional approval for Gilead Sciences Singapore’s experimental antiviral drug remdesivir, under the brand name Veklury, to treat adults with Covid-19.
PeptiDream and Merck partner to develop Covid-19 therapeutics pharmaceutical-technology
June 15, 2020
Japanese biopharmaceutical firm PeptiDream has partnered with Merck (MSD) to discover and develop new peptide therapeutics which could neutralise SARS-CoV-2, the novel coronavirus that causes Covid-19.
AstraZeneca and Emergent Enter COVID-19 Vax Agreement contractpharma
June 15, 2020
Emergent to provide development and manufacturing services and secure large-scale manufacturing capacity through 2020 for AstraZeneca’s COVID-19 vax candidate.
Gemini Bio Wins Federal Contract to Support COVID-19 Testing contractpharma
June 15, 2020
Will be increasing domestic production of reagents from its California facility, as well as its manufacturing footprint.
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir expresspharma
June 15, 2020
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up and obtain regulatory approval for marketing of this drug in respective countries.
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir expresspharma
June 15, 2020
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in Vadodara, formulation facility likely to get inspected.
Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management expresspharma
June 15, 2020
Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of azithromycin has been discontinued.
US FDA seeks fast review of COVID-19 products: Commissioner Stephen Hahn expresspharma
June 12, 2020
Since the onset of the COVID-19 pandemic earlier this year, the FDA has issued a series of temporary emergency approvals ranging from diagnostic tests to treatments such as Gilead Sciences’ antiviral drug remdesivir.
Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19 patients expresspharma
June 12, 2020
Reportedly, some more drugs to be used in combination with hydroxychloroquine may be added to the protocol.
National Jewish Health Offers Expanded COVID-19 Antibody Testing prnewswire
June 11, 2020
National Jewish Health continues to increase its testing capabilities for COVID-19 antibodies, including the addition of new validated testing equipment.